Related Experiment Video
Updated: Jul 1, 2025
09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
23.1K
Which Lipid Nanoparticle (LNP) Designs Work? A Simple Kinetic Model Linking LNP Chemical Structure to In Vivo
Esther H Roh1, Millicent O Sullivan1,2, Thomas H Epps1,3,4
1Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware 19716, United States.
ACS Applied Materials & Interfaces
|March 11, 2024
Summary
Developing novel lipid nanoparticles (LNPs) for short-interfering RNA (siRNA) delivery is accelerated by a new kinetic model. This model predicts LNP efficacy using a key parameter, simplifying formulation design.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery
Background:
- Lipid nanoparticles (LNPs) are primary carriers for short-interfering RNA (siRNA) therapeutics.
- Current LNP formulations are limited and require extensive development due to poor understanding of biological barrier penetration.
Purpose of the Study:
- To develop a predictive model for LNP efficacy in siRNA delivery.
- To identify key LNP properties influencing gene silencing and accelerate formulation design.
Main Methods:
- A simple kinetic model was created based on rate-limiting steps in siRNA delivery.
- The model utilized a volume-averaged log D parameter, representing the pH-dependent solubility of charged molecules, weighted by component volume fractions.
- The model's predictions were validated by assessing gene silencing effects.
Main Results:
- The volume-averaged log D parameter effectively correlated LNP composition with siRNA delivery efficiency.
- The model accurately predicted the impact of ionizable lipid structure and LNP composition on gene silencing.
- This approach significantly simplifies the prediction of LNP formulation performance.
Conclusions:
- A robust structure-activity relationship for LNPs was established, enabling rapid development of effective siRNA delivery systems.
- The kinetic model provides a powerful tool to overcome limitations in current LNP formulation design.
- This work accelerates the realization of diverse and effective LNP-based therapeutics.
